Tagged with ALS

clinical trials The country manager of a British biopharmaceutical company sheds light on Algeria’s potential for conducting clinical trials and offers his views on the quality of the country’s skilled labour. What is the record of your past fourteen months with AstraZeneca? Since I arrived, I have had two priorities. First, I implemented a new…

hospitals Representatives from a French/Austrian consortium that has just been awarded a contract to construct a new University Hospital Centre in Constantine reveal why this sort of turnkey project is highly innovative and represents a landmark moment in the history of Algerian healthcare. Could you please start by introducing your consortium…

pharmaceuticals Boehringer Ingelheim is turning 130 in 2015. Miguel Salazar, president and country managing director for Mexico, explains how he is steering the company to bypass the currents of the ever-changing Mexican market to lead the company to enter the top five in the coming future. How has the pharmaceutical industry…

clinical trials The general manager of a leading British research-based pharmaceutical company discusses Algeria’s suitability as a destination for pre-clinical and clinical trials and assesses the country’s ability to transition from importer to local producer status Can you please start by briefly introducing GSK in Algeria? GSK activities in Algeria span three…

pharmaceuticals The general manager of IMS Health Argentina – South Cone weighs in on why his organization plays a crucial role in the pharma industry in Argentina. How does the Argentinean market look today? The Argentinean market is a solid, mature and competitive business with a lot of potential in biotechnology…

pharmaceuticals The CEO narrates the historic role that the company has played in kickstarting the Algerian home-grown pharmaceuticals industry and outlines ambitious joint venture projects that seek to have a transformative effect on the local sector. Mr. Derkaoui, can you please start by introducing yourself and telling us a little bit…

pharmaceuticals The head of the society speaks out about the state of the pharmacy in Algeria and delivers suggestions for improving the profession. Discussion revolves around the need to create a national agency for pharmacy, the challenge of human capital sourcing and the status and role of hospital pharmacists. The pharmaceutical…

clinical trials The global CEO of Arianne, who herself happens to be American-Algerian, outlines why, in an era of clinical research globalisation, the country has all the right fundamentals in place to establish itself as a leader in conducting clinical trials and how the Algerian genetic code is well suited for testing Western orientated pharmaceutical…

clinical trials LSK Global PS CEO Young-Jack Lee discusses the influence of global CROs on the quality of Korean research, and outlines his own strategy for competing in the marketplace and growth outside of Korea.   When we met you in 2008, you were positive about the growth of Korean CROs and…

Sanofi Sanofi’s Korean affiliate is the fifth largest recipient of clinical trial investments after the United States, France, Germany and the United Kingdom. Kay Bae, general manager, discusses the benefits of clinical testing in Korea and why ‘open innovation’ is important for progress and development.   You became general manager of…

clinical trials The president of Astellas Korea offers his perspectives on Korea as a base for primary and clinical research, and the company’s recent partnerships in the country.   You became president of Astellas Korea in 2011, following a long career at this affiliate. What were the biggest objectives you had when…

clinical trials The head researcher at P&K Skin Research Center discusses the potential of South Korea as a clinical trial hub, and the company’s current expansion plans.   What differentiates P&K Skin from its competitors, and what are the key characteristics of the Korean market that attract foreign patients and companies? We…